Suchergebnisse
Filter
6 Ergebnisse
Sortierung:
World Affairs Online
Community Psychiatry Care: An Urgent Need in Nigeria
Modupeoluwa Omotunde Soroye,1,2 Obinna O Oleribe,3 Simon D Taylor-Robinson4 1School of Public Health, University of Port Harcourt, Port Harcourt, Rivers State, Nigeria; 2Department of Preventive Dentistry, Faculty of Dentistry, University of Port Harcourt, Port Harcourt, Rivers State, Nigeria; 3Klamath Tribal Health & Family Services, Klamath Falls, OR, 97601, USA; 4Department of Surgery and Cancer, St Mary's Hospital Campus, Imperial College London, London, W2 1NY, UKCorrespondence: Obinna O Oleribe Email obinna.oleribe@klm.portland.ihs.govAbstract: Nigeria's mental health policy was formulated in 1991, but it did not make adequate provision for community-based psychiatric care. Since there are only seven government-owned psychiatry facilities in Nigeria and these are always overwhelmed, there is the need to overhaul the existing policy and emphasise the urgency of a shift from inpatient psychiatric mental healthcare towards a community-based multidisciplinary psychiatric healthcare system.Keywords: community psychiatry, Nigeria, depression, mental health
BASE
Possible Reasons Why Sub-Saharan Africa Experienced a Less Severe COVID-19 Pandemic in 2020
Obinna O Oleribe,1 Ahmed AA Suliman,2,3 Simon D Taylor-Robinson,4 Tumani Corrah5 1Office of the Director General, Nigerian Institute of Medical Research, Yabba, Lagos, Nigeria; 2Department of Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan; 3Department of Cardiology, Shab Teaching Hospital, Khartoum, Sudan; 4Department of Surgery and Cancer, Imperial College London, St Mary's Hospital Campus, London, UK; 5Africa Research Excellence Fund, c/o MRC the Gambia Unit @ LSHTM, Fajara, The GambiaCorrespondence: Simon D Taylor-Robinson Email str338333@gmail.comAbstract: Both scientific authorities and governments of nations worldwide were found lacking in their COVID-19 response and management, resulting in significant distrust by the general public in 2020. Scientific and medical bodies often failed to give the right counsel on the appropriate course of action on COVID-19, because proven steps were not known, while many governments around the world took ineffective, late or inappropriate COVID-19 control and containment strategies. If the 2020 COVID-19 incidence rates are to be believed, much of sub-Saharan Africa had a lower disease prevalence than expected. We put forward six factors peculiar to much of sub-Saharan Africa that may have accounted for the pandemic landscape there in 2020. We also discuss why the situation has become more serious in 2021.Keywords: COVID-19, Africa, public health, multidisciplinary care, pandemic
BASE
Valorization and Thermogravimetric Analysis of Periwinkle Shell-Reinforced Aa6061 Aluminum Composites for Enhanced Performance and Sustainability
In: RINENG-D-24-04180
SSRN
COVID-19 Experience: Taking the Right Steps at the Right Time to Prevent Avoidable Morbidity and Mortality in Nigeria and Other Nations of the World
Obinna O Oleribe,1 Princess Osita-Oleribe,2 Babatunde L Salako,3 Temitope A Ishola,4 Michael Fertleman,5 Simon D Taylor-Robinson6 1Excellence and Friends Management Care Centre, Abuja, Nigeria; 2Centre for Family Health Initiative, Abuja, Nigeria; 3Nigeria Institute for Medical Research, Lagos, Nigeria; 4Department of Biochemistry, Covenant University, Ota, Nigeria; 5Cutrale Perioperative & Ageing Group, Department of Bioengineering, Imperial College London, London, UK; 6Department of Surgery and Cancer, Imperial College London, London, UKCorrespondence: Michael Fertleman Cutrale Perioperative & Ageing Group, Department of Bioengineering, 86 Wood Lane, London W12 0BZ, UKEmail m.fertleman@imperial.ac.ukAbstract: The 2020 Coronavirus pandemic has caused countless governmental and societal challenges around the world. Nigeria, Africa's most populous nation, has been exposed in recent years to a series of epidemics including Ebola and Lassa fever. In this paper, we document our perception of the national response to COVID-19 in Nigeria. The response to the pandemic is with a healthcare system that has changed as a result of previous infectious disease outbreaks but in the context of scarce resources typical of many low-middle income countries. We make recommendations regarding what measures should be in place for future epidemics.Keywords: Nigeria, COVID-19, pandemic, prevention
BASE
A cost-effectiveness analysis of provider and community interventions to improve the treatment of uncomplicated malaria in Nigeria: study protocol for a randomized controlled trial
Background: There is mounting evidence of poor adherence by health service personnel to clinical guidelines for malaria following a symptomatic diagnosis. In response to this, the World Health Organization (WHO) recommends that in all settings clinical suspicion of malaria should be confirmed by parasitological diagnosis using microscopy or Rapid Diagnostic Test (RDT). The Government of Nigeria plans to introduce RDTs in public health facilities over the coming year. In this context, we will evaluate the effectiveness and cost-effectiveness of two interventions designed to support the roll-out of RDTs and improve the rational use of ACTs. It is feared that without supporting interventions, non-adherence will remain a serious impediment to implementing malaria treatment guidelines.Methods/design: A three-arm stratified cluster randomized trial is used to compare the effectiveness and cost-effectiveness of: (1) provider malaria training intervention versus expected standard practice in malaria diagnosis and treatment; (2) provider malaria training intervention plus school-based intervention versus expected standard practice; and (3) the combined provider plus school-based intervention versus provider intervention alone. RDTs will be introduced in all arms of the trial. The primary outcome is the proportion of patients attending facilities that report a fever or suspected malaria and receive treatment according to malaria guidelines. This will be measured by surveying patients (or caregivers) as they exit primary health centers, pharmacies, and patent medicine dealers. Cost-effectiveness will be presented in terms of the primary outcome and a range of secondary outcomes, including changes in provider and community knowledge. Costs will be estimated from both a societal and provider perspective using standard economic evaluation methodologies.Trial registration: Clinicaltrials.gov NCT01350752. © 2012 Wiseman et al.; licensee BioMed Central Ltd.
BASE